- Original Release Date:
June 25, 2007
-
Expiration Date: July 1, 2009
- Estimated Time to Complete this
Educational Activity: 2.5 hours
-
Type of Enduring Material: Internet-Based CE
- DISCLAIMER:
The views and observations presented in this
Continuing Education publication are those of the
authors/editors and do not necessarily reflect those of the funders or producers of this publication. Readers are urged
to consult current prescribing and clinical practice
information in any drug, device or procedure discussed in
this publication.
OBJECTIVES
Upon completion of this CE material, the
participant should be able to:
- Describe the major causes of bone loss in patients
with breast cancer.
- Discuss special considerations related to breast
cancer patients on aromatase inhibitors.
- Cite measures that can be taken to prevent and/or
treat bone loss in women with breast cancer.
- Describe the major causes of bone loss in patients
with prostate cancer.
- Cite measures that can be taken to prevent and/or
treat bone loss in men with prostate cancer.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
The newsletter associated with this educational activity was
originally published in Fall 2006. NOF received no commercial
support for the production and printing of the print or online
publication of Osteoporosis: Clinical Updates.
Click Here for Article
Click Here for the Self-Assessment
Software Requirement:
Adobe Acrobat Reader is required to read the text for this
continuing education activity.
If you do not have Adobe Acrobat Reader,
click
here.
|
